| __timestamp | Bristol-Myers Squibb Company | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 293000 |
| Thursday, January 1, 2015 | 5920000000 | 1002000 |
| Friday, January 1, 2016 | 4940000000 | 888000 |
| Sunday, January 1, 2017 | 6411000000 | 19623000 |
| Monday, January 1, 2018 | 6345000000 | 30421000 |
| Tuesday, January 1, 2019 | 6148000000 | 34794000 |
| Wednesday, January 1, 2020 | 11143000000 | 28304000 |
| Friday, January 1, 2021 | 10195000000 | 56886000 |
| Saturday, January 1, 2022 | 9509000000 | 100894000 |
| Sunday, January 1, 2023 | 9299000000 | 159765000 |
| Monday, January 1, 2024 | 11159000000 |
Unlocking the unknown
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company has consistently demonstrated its dedication, with R&D expenses peaking in 2020 at approximately $11 billion, a staggering 145% increase from 2014. This investment underscores their strategic focus on pioneering treatments and therapies.
In contrast, Viridian Therapeutics, Inc., a smaller player in the industry, has shown remarkable growth in its R&D spending. From a modest $293,000 in 2014, their expenses surged to nearly $160 million by 2023, reflecting a robust 54,000% increase. This dramatic rise highlights Viridian's aggressive push towards innovation and development.
These trends reveal a dynamic industry where both established giants and emerging companies are investing heavily in the future of healthcare.
Research and Development Investment: Bristol-Myers Squibb Company vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Pharming Group N.V.
R&D Spending Showdown: Bristol-Myers Squibb Company vs Ultragenyx Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and CymaBay Therapeutics, Inc.
R&D Spending Showdown: Bristol-Myers Squibb Company vs Wave Life Sciences Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Geron Corporation
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Insmed Incorporated vs Viridian Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Xencor, Inc. or Viridian Therapeutics, Inc.: Who Invests More in Innovation?